Hangzhou Yirui Pharmaceutical Technology Co., Ltd

Quick facts

Phase 2 pipeline

• YR001 ointment

Phase 1 pipeline

• YR001 Dose A on high body surface area
• YR001 Dose A on low body surface area
• YR001 Dose A on middle body surface area
• YR001 Dose B on high body surface area
• YR001 Dose B on low body surface area
• YR001 Dose B on middle body surface area

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Hangzhou Yirui Pharmaceutical Technology Co., Ltd portfolio CI brief
• Hangzhou Yirui Pharmaceutical Technology Co., Ltd pipeline updates RSS